Takeda Pharmaceutical Company Overview

  • Status
  • Public
  • Employees
  • 50,000
Employees
  • Stock Symbol
  • 4502
Stock Symbol
  • Investments
  • 44
  • Share Price
  • $34.68
  • (As of Friday Closing)

Takeda Pharmaceutical Company General Information

Description

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.3 trillion in 2019. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 70% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
TKS
Primary Office
  • 1-1, Nihonbashi-Honcho 2-Chome
  • Chuo-Ku
  • Tokyo, 103-8668
  • Japan
+81 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Takeda Pharmaceutical Company Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$34.68 $35.54 $26.64 - $41.15 $54.2B 1.56B 5.03M $0.33

Takeda Pharmaceutical Company Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 96,998,867 90,260,680 69,625,613 44,164,599
Revenue 29,873,034 30,268,671 18,915,530 15,971,882
EBITDA 6,877,372 6,076,408 3,759,631 3,663,284
Net Income 519,713 406,879 1,219,340 1,685,890
Total Assets 117,484,897 118,633,583 124,394,261 38,641,817
Total Debt 46,446,365 47,128,342 51,866,677 9,275,079
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Takeda Pharmaceutical Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Takeda Pharmaceutical Company‘s full profile, request access.

Request a free trial

Takeda Pharmaceutical Company Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.3 trillion in 2019. The company's
Pharmaceuticals
Tokyo, Japan
50,000 As of 2020
00000000

00000

olor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
000000000000000
Tokyo, Japan
00000 As of 0000
0000

000000 0

te velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident
0000 000000000
Tokyo, Japan
00000 As of 0000
00.000
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Takeda Pharmaceutical Company Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eisai Corporation Tokyo, Japan 00000 0000
000000 00000000 Corporation Tokyo, Japan 00000 00.000 00000000 00.000
000000000000000 Corporation Brentford, United Kingdom 00000 00000000000
00000000 000000 Corporate Backed or Acquired Tokyo, Japan 00000 000000000000
00000 Corporation Mumbai, India 00000 00000000
You’re viewing 5 of 31 competitors. Get the full list »

Takeda Pharmaceutical Company Executive Team (44)

Name Title Board Seat Contact Info
Christophe Weber Chief Executive Officer & Board Member
Andrew Plump Ph.D Board Member & President
Masato Iwasaki Director & President, Divisional
Giles Platford President
Rajeev Venkayya MD President
You’re viewing 5 of 44 executive team members. Get the full list »

Takeda Pharmaceutical Company Board Members (17)

Name Representing Role Since
000000 00000 00.0 Takeda Pharmaceutical Company Board Member & President 000 0000
0000000000 00000 Takeda Pharmaceutical Company Chief Executive Officer & Board Member 000 0000
00000 00000000 Takeda Pharmaceutical Company Chief Financial Officer, Finance & Board Member 000 0000
00000 0000000 Self Board Member 000 0000
00000 0000 Takeda Pharmaceutical Company Outside Director 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Takeda Pharmaceutical Company Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Takeda Pharmaceutical Company Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Takeda Pharmaceutical Company‘s full profile, request access.

Request a free trial

Takeda Pharmaceutical Company Investments & Acquisitions (44)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000000 18-Dec-2020 00000 00000 00 0000 Other Healthcare Technology Systems
00000 000000000000 24-Nov-2020 000000000000000000 Biotechnology
0000 000000000000 11-Jun-2020 000000000 Drug Discovery
000000 20-May-2020 00000 00000 00 00000 Clinics/Outpatient Services 0000 0000
AM-Pharma 31-Mar-2020 Later Stage VC 00000 Drug Discovery
You’re viewing 5 of 44 investments and acquisitions. Get the full list »

Takeda Pharmaceutical Company Subsidiaries (9)

Company Name Industry Location Founded
Takeda Consumer Healthcare Company Pharmaceuticals Tokyo, Japan 2016
000000 00000000 Corporate Venture Capital San Diego, CA 0000
0000000 Biotechnology Leuven, Belgium 0000
000000 00000000 Medical Supplies Cambridge, MA 0000
000000 (0000000) Acquirer Konstanz, Germany 0000
You’re viewing 5 of 9 subsidiaries. Get the full list »

Takeda Pharmaceutical Company Exits (8)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 20-May-2020 00000 00000 00 00000 Completed
  • 6 buyers
000000 00000000000 07-Dec-2017 000000000 00000000 00000 Completed
  • 000000 00000000000
000 000000 0000000 15-Feb-2017 00000 0000000 Completed
  • 2 buyers
0000000 0000000000 14-Jun-2016 00000 00000 00 000.00 Completed
  • 7 buyers
Seattle Genetics 17-Jan-2014 PIPE 000 Completed
You’re viewing 5 of 8 exits. Get the full list »